Is Calidi Biotherapeutics, Inc. (CLDI) a Buy, Sell, or Hold?
AMEX : CLDI
Calidi Biotherapeutics, Inc. — Analyst Ratings
$1.63 USD
$0.01 (0.62%)
- Volume
- 159.14K
- Average Volume
- 398.51K
- Market Capitalization
- $750.51K
- P/E Ratio
- -0.02
- Dividend Yield
- 0.00%
- Price Target
- $5.50
- Year High
- $96.94
- Year Low
- $1.49
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.92
Analyst Consensus Summary
Consensus Rating
Sell
2 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-70.4%
vs Current Price
Price Target
$5.50
Average TargetPrice Target Range
Lowest Target
$2.00
-18.5% DOWNSIDE
Average Target
$5.50
Median Estimate
Highest Target
$9.00
-81.9% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 2
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 2 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Robert Burns | $2 | $0.6012 | 2024-03-21 02:32 AM | 232.7% |
| Robert W. Baird | Joel Beatty | $9 | $29.8 | 2023-10-09 10:21 AM | -69.8% |